These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14071544)

  • 21. Action of anaphylactic shock and anaphylatoxin on mast cells and histamine in rats.
    MOTA I
    Br J Pharmacol Chemother; 1957 Dec; 12(4):453-6. PubMed ID: 13489173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RELEASE PROCESSES IN MAST CELLS AND THEIR ACTIVATION BY INJURY.
    UVNAES B
    Ann N Y Acad Sci; 1964 Aug; 116():880-90. PubMed ID: 14212861
    [No Abstract]   [Full Text] [Related]  

  • 23. [THERAPY OF ALOPECIA AREATA BY MAST CELL DEPLETION].
    LANDI G; FINZI AF
    Minerva Dermatol; 1964 Apr; 39():102-4. PubMed ID: 14170197
    [No Abstract]   [Full Text] [Related]  

  • 24. [ACTION OF THE MAST CELL DEPLETOR 48/80 ON SKIN TEMPERATURE IN ALOPECIA AREATA].
    FINZI AF; LANDI G
    Minerva Dermatol; 1964 Apr; 39():99-102. PubMed ID: 14170203
    [No Abstract]   [Full Text] [Related]  

  • 25. ACTION OF VARIOUS DRUGS ON THE TISSUE HISTAMINE AND 5-HYDROXYTRYPTAMINE CONTENTS OF COMMON LABORATORY ANIMALS.
    BHATT KG; JALOTA R; SANYAL RK
    Indian J Med Res; 1964 Jan; 52():52-62. PubMed ID: 14112163
    [No Abstract]   [Full Text] [Related]  

  • 26. EFFECTS OF A HISTAMINE LIBERATOR ON TISSUE AND PLASMA HISTAMINE IN RAT.
    KOWALEWSKI K
    Pol Med Sci Hist Bull; 1965 Jan; 8():18-20. PubMed ID: 14262498
    [No Abstract]   [Full Text] [Related]  

  • 27. [The behavior of the mast cells of the mesentery in the presence of histamine liberators in rats resistant to traumatic shock].
    Romagnoli P
    Boll Soc Ital Biol Sper; 1974 Nov; 50(22):1994-5. PubMed ID: 4142751
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of mast cell disruption and histamine release in rat anaphylaxis in vitro. Comparison with compound 48/80.
    MOTA I; ISHIT T
    Br J Pharmacol Chemother; 1960 Mar; 15(1):82-7. PubMed ID: 14424649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. THE ROLE OF A CHYMOTRYPSIN-LIKE ENZYME IN HISTAMINE RELEASE FROM RAT MAST CELLS.
    PERERA BA; MONGAR JL
    Immunology; 1963 Sep; 6(5):472-7. PubMed ID: 14069724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. INEFFECTIVENESS OF ANTIHISTAMINES TO INHIBIT MAST CELLS DAMAGE BY COMPOUND 48/80 IN MAN.
    SALVATO G
    Acta Allergol; 1963; 18():529-34. PubMed ID: 14120378
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanisms of histamine release by compound 48-80.
    Rothschild AM
    Br J Pharmacol; 1970 Jan; 38(1):253-62. PubMed ID: 4189829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHANGES IN BLOOD AND SKIN LEVELS OF HISTAMINE AND 5-HYDROXYTRYPTAMINE IN RATS AFTER ADMINISTRATION OF COMPOUND 48-80.
    CALDWELL JR; SHELDON WH
    Bull Johns Hopkins Hosp; 1965 Jan; 116():1-16. PubMed ID: 14252690
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacology of histamine liberation. Cationic amphiphilic drugs and mast cells.
    Nosál R
    J Physiol Pharmacol; 1994 Sep; 45(3):377-86. PubMed ID: 7531010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mast cell degranulation and parenchymal cell injury in the rat mesentery.
    Costa JJ; Harris AG; Delano FA; Zweifach BW; Schmid-Schönbein GW
    Microcirculation; 1999 Sep; 6(3):237-44. PubMed ID: 10501097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local degranulation and histamine release from a single rat mast cell by microelectrophoretic application of basic histamine releasers and antigen.
    Tasaka K; Yamasaki H
    Acta Derm Venereol Suppl (Stockh); 1973; 73():167-73. PubMed ID: 4131287
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantitative correlation between degranulation and histamine release following exposure of rat mast cells to compound 48-80 in vitro.
    Nosal R; Slorach SA; Uvnäs B
    Acta Physiol Scand; 1970 Jun; 79(2):31A-32A. PubMed ID: 5454905
    [No Abstract]   [Full Text] [Related]  

  • 37. The inhibition of mast cell damage and histamine release in anaphylaxis by pyridine and diphosphopyridine nucleotidase inhibitors. Comparison with compound 48/80.
    MOTA I; da SILVA W; FERNANDES JF
    Br J Pharmacol Chemother; 1960 Sep; 15(3):405-9. PubMed ID: 13773170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ATTEMPT AT AN INTERPRETATION OF THE MECHANISM OF ACTION OF THE INFLAMMATORY SKIN REACTION CAUSED BY LIBERATION PROCESSES].
    JAQUET H
    Arch Int Pharmacodyn Ther; 1963 Jul; 144():161-84. PubMed ID: 14043642
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantitative correlation between degranulation and histamine release following exposure of rat mast cells to compound 48-80 in vitro.
    Nósal R; Slorach SA; Uvnäs B
    Acta Physiol Scand; 1970 Oct; 80(2):215-21. PubMed ID: 4097580
    [No Abstract]   [Full Text] [Related]  

  • 40. The anti-anaphylactic and histamine-releasing properties of the antihistamines. Their effect on the mast cells.
    MOTA I; da SILVA W
    Br J Pharmacol Chemother; 1960 Sep; 15(3):396-404. PubMed ID: 13773171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.